18768150

Source:http://linkedlifedata.com/resource/pubmed/id/18768150

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0017262, umls-concept:C0018897, umls-concept:C0019564, umls-concept:C0034693, umls-concept:C0185117, umls-concept:C0332281, umls-concept:C0376515, umls-concept:C0392756, umls-concept:C0442805, umls-concept:C2715014, umls-concept:C2911684
pubmed:issue	1
pubmed:dateCreated	2008-12-23
pubmed:abstractText	Evidence from in situ studies supports the role of anti-apoptotic factors in the antidepressant responses of certain psychotropics. The availability of anti-ceramidase pro-apoptocic compound (LCL385) provides an opportunity to test in vivo the relation between hippocampal apopotosis and learned helplessness.
pubmed:grant	http://linkedlifedata.com/resource/pubmed/grant/K08 MH070615-01A1
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/18768150-11305904, http://linkedlifedata.com/resource/pubmed/commentcorrection/18768150-11329053, http://linkedlifedata.com/resource/pubmed/commentcorrection/18768150-11488960, http://linkedlifedata.com/resource/pubmed/commentcorrection/18768150-11599650, http://linkedlifedata.com/resource/pubmed/commentcorrection/18768150-12361666, http://linkedlifedata.com/resource/pubmed/commentcorrection/18768150-12397885, http://linkedlifedata.com/resource/pubmed/commentcorrection/18768150-12644357, http://linkedlifedata.com/resource/pubmed/commentcorrection/18768150-15050859, http://linkedlifedata.com/resource/pubmed/commentcorrection/18768150-15266352, http://linkedlifedata.com/resource/pubmed/commentcorrection/18768150-15893822, http://linkedlifedata.com/resource/pubmed/commentcorrection/18768150-15939837, http://linkedlifedata.com/resource/pubmed/commentcorrection/18768150-16001105, http://linkedlifedata.com/resource/pubmed/commentcorrection/18768150-16095731, http://linkedlifedata.com/resource/pubmed/commentcorrection/18768150-16139271, http://linkedlifedata.com/resource/pubmed/commentcorrection/18768150-16702990, http://linkedlifedata.com/resource/pubmed/commentcorrection/18768150-16901483, http://linkedlifedata.com/resource/pubmed/commentcorrection/18768150-17073656, http://linkedlifedata.com/resource/pubmed/commentcorrection/18768150-17245469, http://linkedlifedata.com/resource/pubmed/commentcorrection/18768150-17510525, http://linkedlifedata.com/resource/pubmed/commentcorrection/18768150-1933387, http://linkedlifedata.com/resource/pubmed/commentcorrection/18768150-7945993, http://linkedlifedata.com/resource/pubmed/commentcorrection/18768150-9164317, http://linkedlifedata.com/resource/pubmed/commentcorrection/18768150-9234045
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/8004872
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/2-N-(tetradecylamino)-1-phenyl-1,3-p..., http://linkedlifedata.com/resource/pubmed/chemical/Acid Ceramidase, http://linkedlifedata.com/resource/pubmed/chemical/Antidepressive Agents, Tricyclic, http://linkedlifedata.com/resource/pubmed/chemical/Ceramides, http://linkedlifedata.com/resource/pubmed/chemical/Desipramine, http://linkedlifedata.com/resource/pubmed/chemical/Enzyme Inhibitors, http://linkedlifedata.com/resource/pubmed/chemical/Myristates, http://linkedlifedata.com/resource/pubmed/chemical/Propanolamines, http://linkedlifedata.com/resource/pubmed/chemical/Proto-Oncogene Proteins c-bcl-2
pubmed:status	MEDLINE
pubmed:month	Jan
pubmed:issn	1872-7549
pubmed:author	pubmed-author:BielawskaAlicjaA, pubmed-author:DevaneLindsayL, pubmed-author:HannunYusuf AYA, pubmed-author:JiangYanY, pubmed-author:KalivasPeterP, pubmed-author:NahasZiadZ, pubmed-author:SzulcZdzislawZ, pubmed-author:ZeidanYoussef HYH
pubmed:issnType	Electronic
pubmed:day	30
pubmed:volume	197
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	41-4
pubmed:dateRevised	2010-9-21
pubmed:meshHeading	pubmed-meshheading:18768150-Acid Ceramidase, pubmed-meshheading:18768150-Analysis of Variance, pubmed-meshheading:18768150-Animals, pubmed-meshheading:18768150-Antidepressive Agents, Tricyclic, pubmed-meshheading:18768150-Apoptosis, pubmed-meshheading:18768150-Ceramides, pubmed-meshheading:18768150-Depression, pubmed-meshheading:18768150-Desipramine, pubmed-meshheading:18768150-Disease Models, Animal, pubmed-meshheading:18768150-Enzyme Inhibitors, pubmed-meshheading:18768150-Helplessness, Learned, pubmed-meshheading:18768150-Hippocampus, pubmed-meshheading:18768150-Male, pubmed-meshheading:18768150-Myristates, pubmed-meshheading:18768150-Propanolamines, pubmed-meshheading:18768150-Proto-Oncogene Proteins c-bcl-2, pubmed-meshheading:18768150-Random Allocation, pubmed-meshheading:18768150-Rats, pubmed-meshheading:18768150-Rats, Sprague-Dawley, pubmed-meshheading:18768150-Stress, Psychological
pubmed:year	2009
pubmed:articleTitle	Anti-ceramidase LCL385 acutely reduces BCL-2 expression in the hippocampus but is not associated with an increase of learned helplessness in rats.
pubmed:affiliation	Mood Disorders Program, University of South Carolina, Charleston, SC 29425, USA.
pubmed:publicationType	Journal Article, Comparative Study, Research Support, Non-U.S. Gov't, Research Support, N.I.H., Extramural